Europe has begun clinical trials of experimental drugs to treat COVID-19 in thousands of patients including a much talked about antimalarial drug.
The trials will include 3,200 patients in the Netherlands, Belgium, Luxembourg, the United Kingdom, France, and Spain. There will be 800 patients in France, where clinical trials were launched this past weekend.
The drug trials include antiviral drugs Remdesivir (used to treat Ebola), Lopinavir/Ritonavir (used to treat HIV/AIDS) and hydroxychloroquine